Treatment

AGEN1777 clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase 1b/2 Study of BMS-986442 in Combination with Nivolumab or Nivolumab and Chemotherapies in Participants with Advanced Solid Tumors and Non-small Cell Lung Cancer
This study is looking into a new drug, BMS-986442, for people with advanced solid tumours, including a type of lung cancer. It combines this new drug with existing cancer medicines to see if it's safe and helps shrink tumours. Researchers are checking for side effects and how well the treatments work.
For: Solid Tumor · Non-small cell lung cancer
Spain · Italy · Poland